SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?
Por um escritor misterioso
Last updated 10 novembro 2024
Rapid antidepressant effects associated with ketamine have shifted the landscape for the
NMDA receptor trafficking in synaptic plasticity and
PDF) Neuroprogression in schizophrenia: Pathways underpinning
The Patient Experience of Recovery Following Anti-NMDA Receptor
Selective Effects of the Loss of NMDA or mGluR5 Receptors in the
PDF) Neuroprogression in schizophrenia: Pathways underpinning
Frontiers Modulation of NMDA receptor activity by CR4056, an
The NMDA receptor antagonist ketamine impairs and delays context
N-Methyl D-aspartate receptor subunit signaling in fear extinction
NMDARs in Cell Survival and Death: Implications in Stroke
Signaling pathways responsible for the rapid antidepressant-like
mGlu1 potentiation enhances prelimbic somatostatin interneuron
Delivering medicines for depression and central nervous system
Molecular mechanisms underlying the antidepressant actions of
Teste 2nd by Second Digital - Issuu
PDF) Neuroprogression in schizophrenia: Pathways underpinning
Recomendado para você
você pode gostar